Clinical Trial Update: Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial from the University of Oklahoma is investigating neuromodulation to reduce cardiovascular risks associated with cardiotoxic chemot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lymphoma

Snippet

Sponsor: University of Oklahoma | Conditions: Breast Cancer, Lymphoma | EARLY_Phase 1 | Status: RECRUITING